Skip to main content

Medpace Holdings, Inc.

corporate_fare Company Profile

Medpace Holdings, Inc.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Exchange: NASDAQSector: Industrial Applications And Services

show_chartPrice Chart

Loading chart...

feed MEDP - Latest Insights

MEDP
Apr 22, 2026, 4:26 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
MEDP
Apr 22, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
MEDP
Apr 22, 2026, 4:15 PM EDT
Source: Reuters
Importance Score:
7
MEDP
Apr 01, 2026, 4:42 PM EDT
Filing Type: DEFA14A
Importance Score:
7
MEDP
Mar 19, 2026, 4:45 PM EDT
Filing Type: 4
Importance Score:
7
MEDP
Mar 17, 2026, 12:37 PM EDT
Filing Type: 144
Importance Score:
7
MEDP
Mar 16, 2026, 5:23 PM EDT
Filing Type: PRE 14A
Importance Score:
8
MEDP
Feb 10, 2026, 4:03 PM EST
Filing Type: 10-K
Importance Score:
7
MEDP
Feb 09, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
7